Lomustine Therapy

Lomustine Therapy is a chemotherapeutic regimen classified under alkylating agent-based pharmacotherapy, distinguished by its use of lomustine, a nitrosourea compound that crosses the blood-brain barrier to exert cytotoxic effects on malignant glioma cells through DNA alkylation and carbamoylation mechanisms.

207

Publications

20.3K

Citations

1.4K

Authors

512

Institutions

Publications per year

2017–2026

50

Authors

1.4K

  1. MJ
    Martin J. van den Bent

    Erasmus MC Cancer Institute, Netherlands

    22 publications · 5.2K citations

    19

    h-index

  2. WW
    Wolfgang Wick

    Heidelberg University, Germany

    20 publications · 4.1K citations

    17

    h-index

  3. MW
    Michael Weller

    University Hospital of Zurich, Switzerland

    18 publications · 3.9K citations

    16

    h-index

  4. AA
    Alba A. Brandes

    Istituti di Ricovero e Cura a Carattere Scientifico, Italy

    16 publications · 3.3K citations

    14

    h-index

  5. JP
    Joachim P. Steinbach

    Goethe University Frankfurt, Germany

    11 publications · 1.4K citations

    11

    h-index

1–5 of 1.4K

Venues

  1. Journal of Clinical Oncology

    30 publications · 6.2K citations

    26

    h-index

  2. Cancer

    12 publications · 709 citations

    12

    h-index

  3. PubMed

    Repository · 18 publications · 719 citations

    12

    h-index

  4. Neuro-Oncology

    11 publications · 987 citations

    11

    h-index

  5. Journal of Veterinary Internal Medicine

    JVIM · 9 publications · 560 citations

    9

    h-index

1–5